Healthcare Online Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Online Network.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 28, 2026

Mar. 28, 2026

BMA CONVENTIONS EMPOWERS FACILITY MANAGERS, DELEGATES & INDUSTRY LEADERS ACROSS THREE PREMIER

EIN Presswire

Mar. 28, 2026

Dr. Majid Alfayyadh: Medical Diplomacy as Platform for Global Collaboration, Trust Building, and Healthier Future

EIN Presswire

Mar. 28, 2026

ProHance Showcases Measurable Productivity Impact at SSOW 2026, Shifting from Transformation to Tangible Outcomes

EIN Presswire

Mar. 28, 2026

C&S Contracting Expands Walk-In Tub Services for Seniors Across Pasco County, Florida

EIN Presswire

Mar. 28, 2026

Gelatin Trick 2026 Warning: Does the Viral Gelatin Trick Recipe Actually Work? — Pink Gelatin Trick, Ice Gelatin Trick, Bariatric Jello, and Why Consumers Are Choosing Gelatine Sculpt Instead (New Investigation)

GlobeNewswire

Mar. 28, 2026

Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men

GlobeNewswire

Mar. 28, 2026

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

GlobeNewswire

Mar. 28, 2026

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

GlobeNewswire

Mar. 28, 2026

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

GlobeNewswire

Mar. 28, 2026

Gelatide Drops Under Investigation: Full Gelatide-1 Consumer Report Reveals Shocking Hidden Risks & Fake Gelatin Trick Recipe

GlobeNewswire

Mar. 28, 2026

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

GlobeNewswire

Mar. 28, 2026

SonusZen Claims Evaluated: Testing the Legitimacy of Sonus Zen Formulation for Hearing Support

GlobeNewswire

Mar. 28, 2026

Communiqué de presse : AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute

GlobeNewswire

Mar. 28, 2026

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

GlobeNewswire

Mar. 28, 2026

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

GlobeNewswire

Mar. 28, 2026

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

GlobeNewswire

Mar. 28, 2026

TheraWolf PainBalm and NeuroBalm Claims Evaluated: What Buyers Are Overlooking About Topical Relief Formulas, Ingredients, and Pricing in 2026

GlobeNewswire